Two new studies examined whether GLP-1 popular weight-loss and diabetes drugs are linked to vision and eye problems in people with type 2 diabetes. One study reported a small uptick in optic nerve disorders among users of semaglutide or tirzepatide. The companion analysis tracked diabetic retinopathy patterns in patients prescribed GLP-1 medicines and assessed serious eye complications. This …
Read More »Tag Archives: WeightLoss
How weight-loss injections are making obesity a wealth issue
Nick TriggleHealth correspondent BBC Three years ago, a fashion editor friend returned from Milan Fashion Week bursting with a story to tell. Most fashion editors stayed at the same hotel, she explained, and each bedroom had its own mini fridge. After checking out, en route to the airport, a stylist in her party cried out that he’d left “an important …
Read More »Weight-loss drugs can cut future health costs. The fight is over who pays now. – The Washington Post
Weight-loss drugs can cut future health costs. The fight is over who pays now. The Washington Post 13 kgs lost in 4 months – how new weight-loss shots are changing lives The Times of India Delaware report shows growing use of GLP-1 meds are driving increased spending, not drug price tags WHYY AI, Personalized Medicine, and GLP-1 Receptor Agonists Reshape Pharmaceutical Commercialization Strategies geneonline.com …
Read More »Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion – The Wall Street Journal
Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion The Wall Street Journal Pfizer expands obesity drug pipeline with $7.3 billion deal to buy Metsera CNBC Pfizer goes full speed ahead on obesity with $4.9B acquisition of Metsera Endpoints News Pfizer to buy Metsera for up to $7.3B Axios Pfizer to buy weight-loss drug developer Metsera for up to $4.9 billion Yahoo …
Read More »Loose skin caused by weight-loss injections dents our confidence
Grace Dean and George Sandeman Emilly Murray @itsanewmeemj Emilly says loose skin “really does get me down” After losing nearly six stone since December with the help of weight-loss injections, Emilly Murray has been left with an unwanted reminder of her former body – loose skin. “I can’t wear what I want to wear,” says the 35-year-old from Liverpool. “I …
Read More »WHO backs weight-loss drugs for obesity and urges change in mindset – Reuters
WHO backs weight-loss drugs for obesity and urges change in mindset Reuters WHO backs weight-loss drugs for obesity K24 Digital WHO backs weight-loss drugs, urges cheap generics daily-sun.com Source link
Read More »Most quit breakthrough weight-loss drug within a year
The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose weight. However, a new population-wide study being presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Vienna (15-19 Sept) finds that half of adults without diabetes who start taking the weight-loss drug semaglutide in …
Read More »Lizzo Wears Form-Fitting Gown, Celebrates Weight-Loss Journey on Instagram
NEED TO KNOW Lizzo showed off her figure in a form-fitting gown at the Canelo Álvarez vs. Terence Crawford Netflix Live Event on Sept. 13 Lizzo also shared a before-and-after video about her weight-loss journey the same day she stepped out at Las Vegas event A day earlier, Lizzo flaunted her figure in a sheer corset look at the Christian …
Read More »Popular Weight-Loss Drugs Like Ozempic Pose Hidden Risks for Young Women, Warn Researchers
An Australian analysis of more than a million primary-care records suggests many women of reproductive age starting GLP-1 receptor agonists for weight loss aren’t using effective contraception, despite potential pregnancy risks. Credit: Stock Researchers warn that widespread use of weight-loss drugs like Ozempic among women of reproductive age may pose hidden risks to pregnancy. Flinders University researchers caution that many …
Read More »Novo Nordisk Cuts Around 9,000 Jobs as Weight-Loss Drugmaker Faces Growing Competition
Key Takeaways Novo Nordisk said it is laying off about about 9,000 positions or 11.5% of its workforce in a “transformation” of the drugmaker’s business. The maker of Ozempic and Wegovy said the cuts are part of a plan to help the company grow its diabetes and weight-loss products. Novo Nordisk expects the job reductions will save about $1.25 billion …
Read More »